Posts/Bluesky/Post Analysis
The Bluesky post
Robert Lufkin MD
@robertlufkinmd.bsky.social·Bluesky·

Honest caveat: this is a mouse study. The mechanism is elegant, but no human trial has shown that a 15-PGDH inhibitor protects muscle in people on GLP-1s. Lifestyle is still the foundation: resistance training plus ~1.6 g/kg of protein remains the proven way to keep muscle on these drugs. (4/6)

Summary

A mouse study suggests a hidden culprit behind muscle loss on weight-loss drugs — and blocking it might help keep muscles strong.

Other research shows that when mice on semaglutide had 15-PGDH blocked, they kept about 30% more muscle mass and regained strength faster after injury — without losing the fat-burning effect. That’s a compelling clue, but the original study linked in the post didn’t actually measure whether semaglutide raises this enzyme at all. It only showed that blocking it reversed muscle loss, which implies a connection but doesn’t prove how it starts. And while the results in mice are striking, no human trials have tested this yet. So we’re seeing a promising puzzle piece, not a finished picture.

If you're on a GLP-1 drug and worried about muscle loss, lifting weights and eating enough protein are still your best bets — but this mouse research might point to a future way to protect muscle without giving up the weight loss.

ReliabilityThe evidence mostly supports this with some caveats
Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.